Repository logo

Views for HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trial.

Total visits

views
HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trial. 262

Total visits per month

views
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0

File Visits

views
Garrett_Nigel_2015.pdf 309
Garrett_Nigel_2015.pdf(legacy) 21

Top country views

views
United States 100
South Africa 50
Sweden 22
Germany 15
Ireland 10
Netherlands 9
Vietnam 9
India 6
China 5
Finland 4
France 4
Russia 4
Singapore 3
Hungary 2
Brazil 1
Switzerland 1
Israel 1
Iraq 1
Slovakia 1

Top city views

views
Ashburn 55
Johannesburg 20
Dublin 10
Hanoi 9
Durban 4
Pretoria 4
Bengaluru 3
Des Moines 3
Washington 3
Guntur 2
Santa Clara 2
Beijing 1
Budapest 1
Cape Town 1
Chicago 1
Heidelberg 1
Kunhegyes 1
Lansing 1
Mumbai 1
Nitra 1
Provo 1
Sandton 1
Seattle 1
Singapore 1
Tel Aviv 1
Tzaneen 1
Valencia 1
Villieria 1
Wuxi 1